S22-307 Leptin analogs to treat obesity Stanford scientists in Chris Garcia's lab have developed leptin analogs that have potentially more favorable pharmacokinetic and pharmacological signaling properties for use as diabetes and obesity drugs. Kenan Christopher Garcia Robert Saxton